Olive Leaf HIF-1 Activator for Stem Cell State Control

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing treatments and compositions do not effectively activate Hypoxia-Inducible Factor-1 (HIF-1) to address diseases or symptoms associated with reduced HIF-1 activity, such as hematopoietic dysfunction, impaired vascularization, and skin aging.

Innovation Solution

A composition comprising olive leaf extract, specifically containing oleuropein and oleuroside, is used to activate HIF-1, promoting stem cell differentiation, maintaining undifferentiated states, and improving dysdifferentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used, then general therapeutic approaches are applied, but HIF-1 activation is insufficient to address diseases with reduced HIF-1 activity

Engineering Contradiction:

ImproveHIF-1 activation efficacyVSAvoidapplicability to HIF-1 related diseases

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameter by introducing olive leaf extract containing oleuropein and oleuroside, which specifically activate HIF-1 through modulation of oxygen sensing pathways and inhibition of prolyl hydroxylase activity, thereby increasing HIF-1 stability and nuclear translocation

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite natural extract containing multiple compounds (oleuropein and oleuroside) that work synergistically to activate HIF-1, combining the effects of phenolic compounds and their metabolites to achieve reliable HIF-1 activation across different disease models

Inventive Principle:

Principle #40Composite materials

2Reliability

If olive leaf extract is used to activate HIF-1, then stem cell differentiation is promoted and diseases are treated, but the complexity of identifying and isolating effective components increases

Engineering Contradiction:

Improvestem cell differentiation inductionVSAvoidcomponent identification and isolation

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and identifies the specific active components (oleuropein and oleuroside) from olive leaf extract that are responsible for HIF-1 activation, separating the effective principles from the complex natural mixture to enable targeted therapeutic application

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses HIF-1 as an intermediary molecule that mediates the effect of olive leaf extract components on stem cell differentiation and disease treatment, providing a clear mechanistic pathway from the natural extract to the biological response

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS12551523B2HIF-1 activator

Publication Date: 2026.02.17 NUTRITION ACT

AI summary

The invention provides an HIF-1 activator for treatment, prevention, alleviation, improvement or recovery from diseases or symptoms associated with reduced HIF-1 activity, as well as a pharmaceutical composition, cosmetic and food composition comprising the activator. Provided is an HIF-1 activator comprising olive leaf extract. Also provided is an HIF-1 activator which is for maintaining the undifferentiated state of stem cells via HIF-1 activation and/or improving dysdifferentiation of stem cells.